Pulmonary embolism: Care standards in 2018.
Pulmonary embolism (PE) is a leading cause of cardiovascular mortality worldwide. Clinical presentation can be diverse, and clinicians should have a high index of suspicion regarding the diagnosis. Evaluation should include detailed history of possible risk factors, physical examination and laboratory tests that would support the diagnosis and help risk-stratify patients. Finally, a dedicated imaging study should be performed in order to make a definitive diagnosis. Decisions regarding short-term, immediate, treatment are dictated by PE risk category. Treatment of low and high-risk PE is relatively straightforward. But treating moderate risk PE is challenging since aggressive treatment is not devoid of potential harm. This review focuses on the acute and chronic treatment of PE. We present risk stratification, guidance as to treatment choice and insights into chronic treatment with available anticoagulants.
['Borohovitz|Ariel|A|', 'Weinberg|Mitchell D|MD|', 'Weinberg|Ido|I|']
D000208:Acute Disease D000284:Administration, Oral D000368:Aged D000925:Anticoagulants D015415:Biomarkers D002908:Chronic Disease D000072226:Computed Tomography Angiography D019468:Disease Management D006801:Humans D008297:Male D020097:Natriuretic Peptide, Brain D017410:Practice Guidelines as Topic D011379:Prognosis D011655:Pulmonary Embolism D018570:Risk Assessment D012720:Severity of Illness Index D059039:Standard of Care D015996:Survival Rate D016896:Treatment Outcome D014336:Troponin
Pulmonary embolism Deep venous thrombosis Venous thromboembolism